INNT
TOTAL INVALIDATION PROCESSED BY THE IB
11/09/2024
Back to search
Official data from USPTO
LIPID INCODE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LIPID INCODE
ST13
US500000079186567Class
5, 10, 42, 44
Filing
79186567
Registration
5248111
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
11/09/2024
Trademark type
Word
Nice classes
5, 10, 42, 44
Filing date
03/07/2016
Registration date
07/25/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/09/2024
Last transaction
02/09/2024
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
O'BRIEN, JENNIFER LYNN
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
GENINCODE U.K., LTD.
FERRER INCODE, S.L.
Representatives
LEIGH ANN LINDQUIST SUGHRUE MION, PLLC
Technical classification
Nice Classes
Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic preparations for medical or veterinary purposes; productsreagents and indicators for medical diagnosticspreparationsreagents and biological indicators for monitoring the diagnosis of Familiar Hypercholesterolemia as well as DLAL (Deficiency in Lysosomal Acid Lipase) for medical or veterinary purposes; Diagnostic agents for medical purposesdiagnostic agents for pharmaceutical use; testing materials for medical usemedical diagnostic reagents and assays for testing of body fluids; pharmaceutical and veterinary productspharmaceutical products for the treatment of Hypercholesterolemia; food supplements for humans or animals; nutraceutical products for therapeutic use and as a dietary supplementnutraceuticals for the treatment of Hypercholesterolemia and nutraceuticals for use as a dietary supplement; Plasters for medical purposesmaterial for dressings; disinfectants
Class 10
Surgicalmedicaldental and veterinary instruments and apparatusmedical instruments and apparatus for use in a genetic diagnostic kit in the diagnosis of Familiar Hypercholesterolemia as well as DLAL (Deficiency in Lysosomal Acid Lipase) procedures; suture materials; instruments and apparatus for medical diagnosticsapparatus for medical diagnostic testing in the fields of Familiar Hypercholesterolemia as well as DLAL (Deficiency in Lysosomal Acid Lipase); automatic analyzers for medical diagnosticsmedical diagnostic instruments for the analysis of body fluids; apparatus for diagnostic testing for medical purposesmedical diagnostic apparatus for testing DNA; diagnostic test kits for detecting diseasesdiagnostic kits consisting primarily of probesbuffers and reagents for use in genetic body fluids testing; apparatus for analyzing DNA in biological samples for medical use; apparatus for collecting samples of body fluidsmedical specimen collection devices in the nature of glass slidescups or bags for the collection of blood or saliva samples; Medical specimen bags for testing purposesbags for medical use in storing blood or saliva samples; Medical specimen bags for testing purposesbags for medical use in collecting blood or saliva samples; Sample preparation device for medical diagnostic usessample preparation columns for medical use; containers for medical samplesblood and saliva containers for medical purposes; devices for taking samples for medical usemedical devices for obtaining body fluid samples; urine sample testing instruments for medical diagnostics in the nature of medical diagnostic apparatus for testing DNA; containers specially designed for transporting samples containing living human cells; holders for sample containersspecimen cup holders; capillary tubes for samples
Class 42
Medical and pharmaceutical research services; research and development services in the field of bacteriology; scientific research services for medical purposes in the field of Familiar HypercholesterolemiaDLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; chemical research and analysis; advisory services relating to pharmaceutical research; technical project studyscientific study and research in the field of the preventiontreatment and management of Familiar HypercholesterolemiaDLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; medical research laboratory services; design and development of apparatus for medical diagnostics; computer-assisted diagnostic testing servicesdiagnostic services in the field of Familiar HypercholesterolemiaDLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; Scientific laboratory servicespreparation of biological samples for research purposes; Scientific laboratory servicespreparation of biological samples for use in testing and analysis in research laboratories
Class 44
Medical services; diagnosis of diseasesmedical diagnosis of Familiar HypercholesterolemiaDLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; medical diagnostic servicestesting and analysismedical diagnostic testingmonitoring and reporting services; genetic testing for diagnostics or treatments for medical purposes; medical information services provided on the Internetreporting of consumer authorized clinical testing results directly to the patient; Medical consultation and information services in the field of medical productsproviding information relating to diagnosticprophylactic and treatment of Familiar HypercholesterolemiaDLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; medicalmedicinal and pharmaceutical consultation services; medical advisory services; medical information servicesproviding medical information; medical analyses for the diagnosis and treatment of peopleproviding medical profiles and medical record analysis and assessments via a website that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms and concernsproviding on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; Medical testing for diagnostic or treatment purposesmedical testing relating to the diagnosis and treatment of people; Medical testing for diagnostic or treatment purposesmedical laboratory services for the analysis of blood and saliva samples; Medical testing for diagnostic or treatment purposesmedical laboratory services for the analysis of samples obtained from patients; Medical testing for diagnostic or treatment purposesmedical laboratory services for the analysis of blood and saliva samples obtained from patients
Publications
History of USPTO decisions and trademark events.
48 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
10/24/2024
INPC
INVALIDATION PROCESSED
10/24/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
10/10/2024
C71T
CANCELLED SECTION 71
02/09/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/24/2022
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/25/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/09/2021
CHLD
CHANGE OF OWNER RECEIVED FROM IB
12/18/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/20/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/20/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/24/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/03/2017
FIMP
FINAL DISPOSITION PROCESSED
11/03/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/25/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
07/25/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/09/2017
PUBO
PUBLISHED FOR OPPOSITION
05/09/2017
GPNX
NOTIFICATION PROCESSED BY IB
05/05/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/19/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/19/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/19/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/31/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/27/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
03/27/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/27/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
03/27/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/27/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/18/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/18/2017
ALIE
ASSIGNED TO LIE
02/16/2017
NREV
NOTICE OF REVIVAL - E-MAILED
02/06/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/03/2017
PETG
PETITION TO REVIVE-GRANTED
02/03/2017
PROA
TEAS PETITION TO REVIVE RECEIVED
02/03/2017
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
01/26/2017
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
01/25/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/03/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/03/2016
RFNT
REFUSAL PROCESSED BY IB
07/16/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/28/2016
RFRR
REFUSAL PROCESSED BY MPU
06/28/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/28/2016
CNRT
NON-FINAL ACTION WRITTEN
06/27/2016
DOCK
ASSIGNED TO EXAMINER
06/20/2016
MAFR
APPLICATION FILING RECEIPT MAILED
05/10/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/06/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/05/2016
Continuous trademark protection
Get notified about every new filing that threatens LIPID INCODE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.